期刊
ANNUAL REVIEW OF MEDICINE, VOL 69
卷 69, 期 -, 页码 319-331出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-med-062016-050343
关键词
genome-driven oncology; precision medicine; basket study; basket trial; knowledgebase
资金
- NCI NIH HHS [R25 CA020449, T32 CA009207] Funding Source: Medline
Understanding a tumor's detailed molecular profile has become increasingly necessary to deliver the standard of care for patients with advanced cancer. Innovations in both tumor genomic sequencing technology and the development of drugs that target molecular alterations have fueled recent gains in genome-driven oncology care. Basket studies, or histology-agnostic clinical trials in genomically selected patients, represent one important research tool to continue making progress in this field. We review key aspects of genome-driven oncology care, including the purpose and utility of basket studies, biostatistical considerations in trial design, genomic knowledgebase development, and patient matching and enrollment models, which are critical for translating our genomic knowledge into clinically meaningful outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据